Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2004
A new cause of neuroglycopenia: "missing the point"
M Al-Mrayat, Y Samarasinghe, H Treml, et al.
Journal of Human Hypertension
|
December 1, 1988
Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes
M D Feher, D J Torrens, W Richmond, et al.
Journal of Human Hypertension
|
August 1, 1995
Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kinetics
T C Hardman, P Croft, R Barlow, et al.
International Journal of STD & AIDS
|
December 24, 1998
Coronary artery disease occurring with protease inhibitor therapy
A K Sullivan, M R Nelson, G J Moyle, et al.
Journal of Human Hypertension
|
October 1, 1990
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects
M D Feher, A D Henderson, J Wadsworth, et al.
FEBS Letters
|
October 10, 1988
Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets
R C Dunn, M Schachter, C M Miles, et al.
Journal of the Royal Society of Medicine
|
March 1, 1990
Acute changes in atherogenic and thrombogenic factors with cessation of smoking
M D Feher, M W Rampling, J Brown, et al.
Postgraduate Medical Journal
|
December 1, 1988
Beta-blockers, lipoproteins and non-insulin dependent diabetes
M D Feher, S G Rains, W Richmond, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2004
The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study)
R S Elkeles, M D Feher, M D Flather, et al.
Atherosclerosis
|
November 1, 1993
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
M D Feher, J C Webb, D D Patel, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2004
A new cause of neuroglycopenia: "missing the point"
M Al-Mrayat, Y Samarasinghe, H Treml, et al.
Journal of Human Hypertension
|
December 1, 1988
Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes
M D Feher, D J Torrens, W Richmond, et al.
Journal of Human Hypertension
|
August 1, 1995
Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kinetics
T C Hardman, P Croft, R Barlow, et al.
International Journal of STD & AIDS
|
December 24, 1998
Coronary artery disease occurring with protease inhibitor therapy
A K Sullivan, M R Nelson, G J Moyle, et al.
Journal of Human Hypertension
|
October 1, 1990
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects
M D Feher, A D Henderson, J Wadsworth, et al.
FEBS Letters
|
October 10, 1988
Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets
R C Dunn, M Schachter, C M Miles, et al.
Journal of the Royal Society of Medicine
|
March 1, 1990
Acute changes in atherogenic and thrombogenic factors with cessation of smoking
M D Feher, M W Rampling, J Brown, et al.
Postgraduate Medical Journal
|
December 1, 1988
Beta-blockers, lipoproteins and non-insulin dependent diabetes
M D Feher, S G Rains, W Richmond, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2004
The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study)
R S Elkeles, M D Feher, M D Flather, et al.
Atherosclerosis
|
November 1, 1993
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
M D Feher, J C Webb, D D Patel, et al.
Page
of 8